Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland · Delayed Price · Currency is CHF 49.60
-0.60 (-1.20%)
Jun 2, 2026, 5:30 PM CET
Basilea Pharmaceutica AG Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Basilea Pharmaceutica AG stock has a consensus rating of "Buy" and an average price target of CHF 89.90. The average 1-year stock price forecast is 81.25% higher than the current stock price, while the lowest is CHF 59.40 (+19.76%) and the highest is CHF 120.00 (+141.94%).
Price Target: CHF 89.90 (+81.25%)
Analyst Consensus: Buy
* Price targets were last updated on Apr 13, 2026.
Analyst Ratings
The average analyst rating for Basilea Pharmaceutica AG stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Kepler Capital | Kepler Capital | Buy Maintains CHF 69.00 → CHF 70.00 | Buy | Maintains | CHF 69.00 → CHF 70.00 | +41.13% | Apr 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates CHF 105.00 | Buy | Reiterates | CHF 105.00 | +111.69% | Dec 12, 2025 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.